ClinicalTrials.gg
RecruitingNCT06332989STROKE-APPUpdated Mar 27, 2024

Stroke Triage Optimization by Ambulance Paramedics in the Pre-hospital Setting

An observational study in Stroke, Acute, Pre-hospital Triage and Stroke Treatment, sponsored by Leiden University Medical Center. Recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-27.

Sponsored by Leiden University Medical Center · Observational

How we know

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 122 studies in Stroke with a site in Netherlands — 23 open to participants now, 31 under way, 5 of them phase 3. Stroke · Netherlands.

Planned enrollment
5th of 31
3,000 · median 432
Started
2024
with 3 others
Observational
31 of 122
7 open now
Primary completion
2027-02
later than 13 of 30 live
Registered
110th of 122
by date
Lead sponsor
4 of 122
Leiden University Medical Center

Among the 122 studies in Stroke with a site in Netherlands, this one is the 5th largest by planned enrollment of the 31 observational ones that give a count, is one of 4 that started in 2024, is one of 31 observational ones, reaches primary completion later than 13 of the 30 other live ones, and was the 110th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

23 of the 122 studies in Stroke with a site in Netherlands are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 122 studies in Stroke with a site in Netherlands, or all of them as a file.
02

Study summary

There are everal scales designed to help ambulance paramedics to identify a patient with a stroke and activate a stroke code. These scales were never tested in the field in a large unselected patient sample. We aim to perform an in-the field head tot head comparison of all published stroke scales designed to be used by ambulance paramedics

Read the detailed description

this is a multicenter multiregional cohort study including about 3000 stroke code patients. In all patients an application will be filled out before hospital arrival including items that enable us to reconstruct all previously published stroke scales.

Data from the application will be related to in hospital data of the same patient. In order to do this we will use a trusted third party for data coupling.

03

Conditions studied

  • Stroke, Acute
  • Pre-hospital Triage
  • Stroke Treatment
  • Stroke Code

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients for whom a stroke code was activated.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients for whom a stroke code is activated

Exclusion criteria

Exclusion Criteria:

\< 18 years

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Patient registry
No

Interventions

  • Otherstroke-APP

    Ambulane paramedics will use an online application to fill in several observations on scen

06

What researchers measure

Primary outcomes

  1. final diagnosis

    Diangosis by treating physician

    Time frame: discharge or after 3 months

  2. treated with reperfusion therapy

    treatment with IV thrombolysis; endovascular therapy or surgery

    Time frame: first 24 hours after admission

  3. additional investigations

    CT scans performed

    Time frame: on admission

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Feb 2027, 36 months after the start.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 36 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2024
First posted
Mar 27, 2024
StartActual
Feb 1, 2024
Primary completionEst.
Feb 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Mar 27, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06332989
Collaborators
Alrijne Ziekenhuis Leiderdorp, Groene Hart Ziekenhuis, Medical Center Haaglanden, HagaZiekenhuis, Reinier de Graaf Groep, Regionale Ambulance Voorziening Hollands Midden
Responsible party
NyikaKruyt (M, PhD, Leiden University Medical Center) — Principal investigator
First posted
Mar 27, 2024
Start date
Feb 1, 2024
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Mar 27, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion